MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Genetic Profile of Cerebellar Ataxias in Patients from a Reference Center in Brazil

S. Baran, N. Dos Santos, G. de Vasconcelos, J. Costa, R. Kauark, F. Brito (Salvador, Brazil)

Meeting: 2025 International Congress

Keywords: Ataxia: Genetics, Spinocerebellar ataxia

Category: Functional Movement Disorders / Psychogenic Movement Disorders

Objective: To describe the genetic profile of patients with cerebellar ataxias followed in a neurogenetics reference center in Brazil

Background: Cerebellar ataxias comprise a heterogeneous group of neurodegenerative disorders, often associated with genetic mutations affecting motor coordination and balance. Spinocerebellar Ataxias (SCA) and other hereditary ataxias are among the most frequent causes.

Method: This cross-sectional study was conducted with patients evaluated for hereditary movement disorders in Bahia, Brazil. The clinical and genetic profile data were collected through medical record reviews.

Results: A total of 19 patients with cerebellar ataxia were identified, with 7 cases of undetermined etiology. All of the identified types are of genetic cause. The most frequent diagnosis was Spinocerebellar Ataxia Type 3 (SCA3), with 3 confirmed and 1 suspected case. Other diagnoses included Friedreich’s Ataxia, SCA2, SPG7, Ataxia with Oculomotor Apraxia Type 2 (AOA2), SCAR8 and Ataxia due to Vitamin E Deficiency. Genetic tests confirmed expansions of CAG repeats in the ATXN3 gene (for SCA3), ranging from 24 to 67 repeats. Some patients are still awaiting genetic testing. The mean age of the patients was 45 years (ranging from 19 to 64 years).

Conclusion: Genetic testing played a crucial role in confirming the diagnosis for most cases, serving as an essential tool for clinical management. The predominance of SCA3 reflects its relevance among hereditary ataxias. Expanding access to genetic testing and multidisciplinary follow-up may improve early diagnosis and tailored therapeutic approaches for these patients.

To cite this abstract in AMA style:

S. Baran, N. Dos Santos, G. de Vasconcelos, J. Costa, R. Kauark, F. Brito. Genetic Profile of Cerebellar Ataxias in Patients from a Reference Center in Brazil [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/genetic-profile-of-cerebellar-ataxias-in-patients-from-a-reference-center-in-brazil/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/genetic-profile-of-cerebellar-ataxias-in-patients-from-a-reference-center-in-brazil/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley